These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21233431)

  • 21. Adherence, sexual risk, and viral load in HIV-infected women prescribed antiretroviral therapy.
    Holstad MM; Diiorio C; McCarty F
    AIDS Patient Care STDS; 2011 Jul; 25(7):431-8. PubMed ID: 21663541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
    Sangani P; Rutherford G; Wilkinson D
    Cochrane Database Syst Rev; 2004; (2):CD001220. PubMed ID: 15106156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adapting behavioural surveillance to antiretroviral-based HIV prevention: reviewing and anticipating trends in the Australian Gay Community Periodic Surveys.
    Holt M; Lea T; Mao L; Zablotska I; Lee E; de Wit JBF; Prestage G
    Sex Health; 2017 Feb; 14(1):72-79. PubMed ID: 27567489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-exposure prophylaxis for HIV following possible sexual transmission: an ethical evaluation.
    Gisondi MA
    Camb Q Healthc Ethics; 2000; 9(3):411-7. PubMed ID: 10858892
    [No Abstract]   [Full Text] [Related]  

  • 25. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users.
    Purcell DW; Latka MH; Metsch LR; Latkin CA; Gómez CA; Mizuno Y; Arnsten JH; Wilkinson JD; Knight KR; Knowlton AR; Santibanez S; Tobin KE; Rose CD; Valverde EE; Gourevitch MN; Eldred L; Borkowf CB;
    J Acquir Immune Defic Syndr; 2007 Nov; 46 Suppl 2():S35-47. PubMed ID: 18089983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV sexual transmission risks in the context of clinical care: a prospective study of behavioural correlates of HIV suppression in a community sample, Atlanta, GA, USA.
    Kalichman SC; Cherry C; Kalichman MO; Washington C; Grebler T; Merely C; Welles B; Pellowski J; Kegler C
    J Int AIDS Soc; 2015; 18(1):19930. PubMed ID: 26249127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a peer-led behavioral intervention to reduce HIV transmission and promote serostatus disclosure among HIV-seropositive gay and bisexual men.
    Wolitski RJ; Gómez CA; Parsons JT
    AIDS; 2005 Apr; 19 Suppl 1():S99-109. PubMed ID: 15838199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi.
    Kim MH; Tembo TA; Mazenga A; Yu X; Myer L; Sabelli R; Flick R; Hartig M; Wetzel E; Simon K; Ahmed S; Nyirenda R; Kazembe PN; Mphande M; Mkandawire A; Chitani MJ; Markham C; Ciaranello A; Abrams EJ
    Trials; 2020 Feb; 21(1):207. PubMed ID: 32075677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact on sexually transmitted disease spread of increased condom use by young females, 1987-1992.
    Stigum H; Magnus P; Veierød M; Bakketeig LS
    Int J Epidemiol; 1995 Aug; 24(4):813-20. PubMed ID: 8550280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of antiretroviral drugs to prevent sexual transmission of HIV.
    Cohen MS; Hosseinipour M; Kashuba A; Butera S
    Curr Clin Top Infect Dis; 2002; 22():214-51. PubMed ID: 12520656
    [No Abstract]   [Full Text] [Related]  

  • 31. Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus.
    Blocker ME; Cohen MS
    Infect Dis Clin North Am; 2000 Dec; 14(4):983-99. PubMed ID: 11144648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safer sexual behaviors after 12 months of antiretroviral treatment in Mombasa, Kenya: a prospective cohort.
    Luchters S; Sarna A; Geibel S; Chersich MF; Munyao P; Kaai S; Mandaliya KN; Shikely KS; Rutenberg N; Temmerman M
    AIDS Patient Care STDS; 2008 Jul; 22(7):587-94. PubMed ID: 18601582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV/AIDS and African American men: urban-rural differentials in sexual behavior, HIV knowledge, and attitude towards condoms use.
    Williams PB; Sallar AM
    J Natl Med Assoc; 2010 Dec; 102(12):1139-49. PubMed ID: 21287894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention.
    Kalichman SC; Eaton L; Cherry C
    HIV Med; 2010 Sep; 11(8):502-9. PubMed ID: 20201976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program.
    Wingood GM; DiClemente RJ; Mikhail I; Lang DL; McCree DH; Davies SL; Hardin JW; Hook EW; Saag M
    J Acquir Immune Defic Syndr; 2004 Oct; 37 Suppl 2():S58-67. PubMed ID: 15385901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Text messaging for maternal and infant retention in prevention of mother-to-child HIV transmission services: A pragmatic stepped-wedge cluster-randomized trial in Kenya.
    Odeny TA; Hughes JP; Bukusi EA; Akama E; Geng EH; Holmes KK; McClelland RS
    PLoS Med; 2019 Oct; 16(10):e1002924. PubMed ID: 31577792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linguistic and Cultural Adaptation of a Computer-Based Counseling Program (CARE+ Spanish) to Support HIV Treatment Adherence and Risk Reduction for People Living With HIV/AIDS: A Randomized Controlled Trial.
    Kurth AE; Chhun N; Cleland CM; Crespo-Fierro M; Parés-Avila JA; Lizcano JA; Norman RG; Shedlin MG; Johnston BE; Sharp VL
    J Med Internet Res; 2016 Jul; 18(7):e195. PubMed ID: 27417531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intentional Medication Nonadherence Because of Interactive Toxicity Beliefs Among HIV-Positive Active Drug Users.
    Kalichman SC; Kalichman MO; Cherry C; Hoyt G; Washington C; Grebler T; Welles B; Merely C
    J Acquir Immune Defic Syndr; 2015 Dec; 70(5):503-9. PubMed ID: 26226250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users.
    Copenhaver MM; Lee IC; Margolin A; Bruce RD; Altice FL
    Subst Abus; 2011 Jan; 32(1):16-26. PubMed ID: 21302180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral interventions to promote condom use among women living with HIV.
    Carvalho FT; Gonçalves TR; Faria ER; Shoveller JA; Piccinini CA; Ramos MC; Medeiros LR
    Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD007844. PubMed ID: 21901711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.